Texas Yale Capital’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-833
Closed -$6K – 450
2017
Q4
$6K Hold
833
– – ﹤0.01% 438
2017
Q3
$7K Hold
833
– – ﹤0.01% 442
2017
Q2
$7K Hold
833
– – ﹤0.01% 447
2017
Q1
$6K Hold
833
– – ﹤0.01% 442
2016
Q4
$6K Buy
+833
New +$7.19K ﹤0.01% 426
2016
Q3
– Sell
-833
Closed -$19K – 447
2016
Q2
$19K Hold
833
– – ﹤0.01% 448
2016
Q1
$27K Hold
833
– – ﹤0.01% 445
2015
Q4
$28K Buy
+833
New +$29.3K ﹤0.01% 441
2015
Q3
– Sell
-833
Closed -$35K – 491
2015
Q2
$35K Buy
+833
New +$42.4K ﹤0.01% 473
2015
Q1
– Sell
-833
Closed -$30K – 484
2014
Q4
$30K Hold
833
– – ﹤0.01% 459
2014
Q3
$45K Buy
+833
New +$55.4K ﹤0.01% 427

Other funds holding XTNT

Texas Yale Capital's XTNT Position: Q1 2018 in Review

Texas Yale Capital sold out of Xtant Medical Holdings (XTNT) in Q1 2018, closing a stake of 833 shares — an estimated $6K sold.

Texas Yale Capital first reported a position in XTNT in Q3 2014 and held it in 11 quarters. The position peaked at $45K in Q3 2014. 14 funds tracked by Wall St. Rank hold XTNT as of Q1 2018.

  • Texas Yale Capital reported no remaining Xtant Medical Holdings position as of Q1 2018 after selling out during the quarter.
  • Texas Yale Capital sold 833 Xtant Medical Holdings shares in Q1 2018, an estimated $6K.
  • Texas Yale Capital first reported a position in Xtant Medical Holdings in Q3 2014 and held it in 11 quarters.
  • Texas Yale Capital's Xtant Medical Holdings position peaked at $45K in Q3 2014.
  • 14 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2018.

Based on Texas Yale Capital's 13F filing for Q1 2018, filed 3 May 2018.